We detected the expression levels of the stemness markers including OCT4, SOX2, and Nanog, finding that DUSP3 upregulation significantly decreased their expression levels (Figure 4A-C); conversely, DUSP3 downregulation resulted in a noticeably higher levels of cancer stemness markers (Figure 4D-F). The gene discussed is DUSP3; the disease is cancer.